CR8772A - Nuevos derivados de indazol e indolona y su uso como productos farmaceuticos - Google Patents

Nuevos derivados de indazol e indolona y su uso como productos farmaceuticos

Info

Publication number
CR8772A
CR8772A CR8772A CR8772A CR8772A CR 8772 A CR8772 A CR 8772A CR 8772 A CR8772 A CR 8772A CR 8772 A CR8772 A CR 8772A CR 8772 A CR8772 A CR 8772A
Authority
CR
Costa Rica
Prior art keywords
indolona
indazol
pharmaceutical products
new derivatives
class
Prior art date
Application number
CR8772A
Other languages
English (en)
Inventor
Moira Norfor Allerton Charlotte
Hepworth David
Charles Miller Duncan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411810A external-priority patent/GB0411810D0/en
Priority claimed from GB0415455A external-priority patent/GB0415455D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of CR8772A publication Critical patent/CR8772A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se refiere a una clase de agonistas de dopamina, mas particularmente una clase de agonistas que son selectivos por D3 frente a D2
CR8772A 2004-05-26 2006-11-24 Nuevos derivados de indazol e indolona y su uso como productos farmaceuticos CR8772A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0411810A GB0411810D0 (en) 2004-05-26 2004-05-26 New indazole and indolone derivatives and their use as pharmaceuticals
GB0415455A GB0415455D0 (en) 2004-07-09 2004-07-09 New indazole and indolone derivatives and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
CR8772A true CR8772A (es) 2006-12-13

Family

ID=35219654

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8772A CR8772A (es) 2004-05-26 2006-11-24 Nuevos derivados de indazol e indolona y su uso como productos farmaceuticos

Country Status (25)

Country Link
EP (1) EP1753763B1 (es)
JP (2) JP4093588B2 (es)
AP (1) AP2006003823A0 (es)
AR (1) AR049191A1 (es)
AT (1) ATE404560T1 (es)
AU (1) AU2005247696A1 (es)
BR (1) BRPI0511533A (es)
CA (1) CA2568050A1 (es)
CR (1) CR8772A (es)
DE (1) DE602005008954D1 (es)
EA (1) EA200601985A1 (es)
EC (1) ECSP067024A (es)
ES (1) ES2308492T3 (es)
GT (1) GT200500118A (es)
IL (1) IL179365A0 (es)
MA (1) MA28606B1 (es)
MX (1) MXPA06013759A (es)
NL (1) NL1029128C2 (es)
NO (1) NO20065328L (es)
PA (1) PA8635001A1 (es)
PE (1) PE20060289A1 (es)
SV (1) SV2005002128A (es)
TW (1) TW200607500A (es)
UY (1) UY28918A1 (es)
WO (1) WO2005116027A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR078411A1 (es) 2009-05-07 2011-11-09 Lilly Co Eli Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
CA2860453C (en) * 2011-01-24 2020-04-28 Inceptum Research & Therapeutics, Inc. Compositions comprising a prostaglandin for treating neuropsychiatric conditions
CA2965741C (en) * 2014-11-03 2022-05-17 Iomet Pharma Ltd Pharmaceutical compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023035A2 (en) * 1992-05-18 1993-11-25 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
AU6246198A (en) * 1997-02-18 1998-09-08 American Home Products Corporation 4-aminoethoxyindazole derivatives
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
PT1572214E (pt) * 2002-12-10 2010-05-06 Pfizer Morfolina derivados para utilização como agonistas da dopamina no tratamento da disfunção sexual i.a.

Also Published As

Publication number Publication date
PE20060289A1 (es) 2006-04-22
IL179365A0 (en) 2007-03-08
WO2005116027A3 (en) 2006-04-13
TW200607500A (en) 2006-03-01
BRPI0511533A (pt) 2008-01-02
ATE404560T1 (de) 2008-08-15
ES2308492T3 (es) 2008-12-01
NL1029128A1 (nl) 2005-11-30
DE602005008954D1 (de) 2008-09-25
EP1753763B1 (en) 2008-08-13
MXPA06013759A (es) 2007-02-08
EP1753763A2 (en) 2007-02-21
JP2008500329A (ja) 2008-01-10
GT200500118A (es) 2006-01-10
AU2005247696A1 (en) 2005-12-08
JP4093588B2 (ja) 2008-06-04
NL1029128C2 (nl) 2006-06-14
ECSP067024A (es) 2006-12-29
EA200601985A1 (ru) 2007-04-27
CA2568050A1 (en) 2005-12-08
MA28606B1 (fr) 2007-05-02
PA8635001A1 (es) 2006-05-16
WO2005116027A2 (en) 2005-12-08
UY28918A1 (es) 2005-12-30
JP2008074874A (ja) 2008-04-03
SV2005002128A (es) 2005-12-13
NO20065328L (no) 2006-12-18
AR049191A1 (es) 2006-07-05
AP2006003823A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
NI200800217A (es) Arildihidroisoquinolinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos.
UY30709A1 (es) Nuevos derivados de 1,4-benzotiepina-1, 1-dioxido sustituidos con radicales bencilo, método para su preparacion, productos farmacéuticos que comprenden estos compuestos y su uso.
CR9695A (es) Asociacion de un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion corta y su aplicacion en terapeutica.
CL2008002538A1 (es) Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral
CL2008002539A1 (es) Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral
DOP2007000016A (es) Agentes citotoxicos que comprenden nuevos derivados de tomaimicina.
SV2009002858A (es) Nueva forma polimorfica y la forma amorfa de 5- cloro-n-([(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il]-metil)-2-tiofenocarboxamida
AR059358A1 (es) Formulaciones farmaceuticas
NI201000005A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico.
CL2008001815A1 (es) Compuestos derivados de indazol; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar cancer.
HN2007000437A (es) Compuestos de pirazolina y su uso y composiciones farmaceuticas
CO6210786A2 (es) Implemento de cuidado oral que alberga un agente de cuidado oral
ECSP11011340A (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
UY30165A1 (es) Nuevas arildihidroisoquinolinonas sustituidas con aminolcoholes, procedimiento para su preparación y su uso como medicamentos
AR081670A1 (es) Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
UY30163A1 (es) Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
UY30534A1 (es) Derivados de 5,6-bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapéutica como antagonistas de los receptores de urotensina ii
GT201400063A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
UY30164A1 (es) Nuevas ariltienopirimidinonas sustituidas con aminoalcoholes, procedimiento para su preparación y su uso como medicamentos
MX2009010103A (es) Composiciones estructuradas que comprenden una arcilla.
AR059423A1 (es) Administracion oral de agentes terapeuticos usando agonistas de uniones impermeables
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
HN2006037713A (es) Compuestos utiles en terapia
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53